ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Early Rhythm-Control Therapy in Patients With Atrial Fibrillation

Thursday, October 1, 2020

Submitted by

Aristotle Protopapas

Source

Source Name: The New England Journal of Medicine
Source URL: https://www.nejm.org/doi/full/10.1056/NEJMoa2019422

Author(s)

Paulus Kirchhof, A. John Camm, Andreas Goette, Axel Brandes, Lars Eckardt, Arif Elvan, Thomas Fetsch, Isabelle C. van Gelder, Doreen Haase, Laurent M. Haegeli, Frank Hamann, Hein Heidbüchel, Gerhard Hindricks, Josef Kautzner, Karl-Heinz Kuck, Lluis Mont, G. Andre Ng, Jerzy Rekosz, Norbert Schoen, Ulrich Schotten, Anna Suling, Jens Taggeselle, Sakis Themistoclakis, Eik Vettorazzi, Panos Vardas, Karl Wegscheider, Stephan Willems, Harry J.G.M. Crijns, Günter Breithardt, for the EAST-AFNET 4 Trial Investigators

Death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome was reduced (P=0.005) by early pharmacogical or inteventional ablation for fast response-atrial fibrillation in a small German RCT. 

Add comment

Log in or register to post comments
Printer-friendlyPrinter-friendly

Rate article

Share

Twitter logo Facebook logo Google+ logo LinkedIn logo
See all JANS Notes

Tags